The size of China's farm animal drug market will reach 100 million yuan (RMB) in 2023, and the global farm animal drug market will reach 100 million yuan in the same year. Combined with the industry development environment and market dynamics, the farm animal drug industry research report makes a reasonable prediction of the farm animal drug market trend during the forecast period. The global farm animal drugs market is expected to grow at a CAGR of % during the forecast period, and the total size of the global farm animal drugs market is forecast to reach 100 million yuan by 2029.
The report analyzes the segmentation by product type and end application, and studies the market volume, market share and growth trend of each segment. By product category, the farm animal pharmaceutical industry can be segmented into Other Locations, Oral, Topical, Gastrointestinal/Gastroenteral. In terms of end-use classification, farm animal drugs can be applied to ruminants, poultry, livestock, pigs, horses and other fields.
中国农场动物药行业内主要企业为Alembic Animal Health, Ashish Life Sciences, Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health (Sub. Eli Lilly), Hester Biosciences, Intas Animal Health, Kyoritsu Seiyaku Corporation, Merck Animal Health, Nippon Zenyaku Kogyo Co., Ltd, Norbrook, Ouro Fino Saude Animal (Ourofino), Phibro Animal Health Corporation, Sequent Scientific, Vetoquinol SA, Virbac SA, Zoetis, Inc., Zydus Animal Health (Sub. Cadila Healthcare Ltd)。 报告包含了对主要企业发展概况的介绍,包括公司简介、主要产品及服务、农场动物药销量、农场动物药价格、及市场收入等方面。
The research report on the farm animal drug industry conducts in-depth research and analysis on the market trend of domestic farm animal medicine, and investigates the overview, development environment, upstream and downstream conditions, market supply and demand status, competition degree of farm animal drug industry, development status of major regions, market drivers and hindrance factors. The report comprehensively counts the market size and growth rate of farm animal drugs in the past five years, and predicts the development prospects of the farm animal drug market in the next six years, helping companies to clearly understand the market overview and development trends.
Front-end enterprises in the farm animal medicine industry:
Alembic Animal Health
Ashish Life Sciences
Bayer AG
Boehringer Ingelheim GmbH
Ceva Sante Animal
Dechra Pharmaceuticals PLC
Elanco Animal Health (Sub. Eli Lilly)
Hester Biosciences
Intas Animal Health
Kioritsu Cheyyaku Corporation
Merck Animal Health
Nippon is a co-operative.
Ltd
Norbrook
Ouro Fino Animal Health (Ourofino)
Phibro Animal Health Corporation
Sequent Scientific
Vetoquinol SA
Virbac SA
Zoetis
Inc.
Zydus Animal Health (Sub. Cadila Healthcare Ltd)
Product Category Breakdown:
Other locations
take orally
part
Gastrointestinal/gastrointestinal
Downstream Application Market:
ruminant
poultry
livestock
pig
horse
This report provides a detailed analysis of the development of the farm animal drug industry in various regions of China, and analyzes and interprets the development degree and development status of key regions in North China, East China, South China, and Central China in combination with the characteristics and industrial policies of each region, as well as the advantages and disadvantages of the development of the farm animal drug industry in each region, so as to help enterprises seize potential opportunities.
Overview of each chapter of the farm animal drug industry research report:
Chapter 1: Definition and characteristics of farm animal drugs, subdivision types and applications, and introduction of upstream and downstream industry chains;
Chapter 2: Analysis of the development status of the upstream and downstream industries of China's farm animal drug industry, the current development cycle, and the relevant domestic policies and industry influencing factors;
Chapter 3: Market size, development advantages and disadvantages of China's farm animal drug industry, the position of China's farm animal drug industry in the global market, and market concentration analysis;
Chapter 4 explains the development degree of the farm animal drug industry in different regions of China, and analyzes the development status and advantages and disadvantages of the industry in North China, East China, South China, and Central China in turn.
Chapter 5: This chapter contains the analysis of the import and export situation, quantity difference and influencing factors of China's farm animal medicine industry;
Chapters 6 and 7 analyze the sales volume and sales volume of the subdivided categories and downstream application markets of the farm animal drug industry in turn, and also include the sales price and influencing factors of each product type, as well as the application status and demand analysis of the main fields.
Chapter 8: Geographical distribution of enterprises in China's farm animal medicine industry and the advantages and disadvantages of key enterprises in global competition;
Chapter 9: details the basic situation of the main enterprises in China's farm animal medicine industry, the introduction of main products and services, the sales volume, sales revenue, price, gross profit, gross profit margin, and development strategy of farm animal medicine;
Chapter 10: Analysis of the driving constraints, competitive landscape and key technology development trends of China's farm animal drug industry;
Chapter 11: This chapter contains forecasts for market size, segmentation type and application of China's farm animal medicine industry market volume and sales forecast;
Chapter 12: Farm Animal Drug Industry Entry Barriers, Return Cycle, Hot Spots, and Strategy Analysis.
Publisher: Hunan Beijiesi Information Consulting Co., Ltd
directory
Chapter 1 Overview of the Farm Animal Drug Industry
1.1 Farm Animal Drugs Definition and Industry Overview
1.2 Classification of the national economy to which farm animal drugs belong
1.3 Product classification of farm animal medicine industry
1.4 Introduction to the downstream application fields of the farm animal medicine industry
1.5 Analysis of the industrial chain of the farm animal medicine industry
1.5.1 Introduction to the upstream industry of farm animal medicine industry
1.5.2 Analysis of downstream customers in the farm animal medicine industry
Chapter 2 The latest market analysis of China's farm animal drug industry
2.1 Development status of the main upstream industries of China's farm animal drug industry
2.2 Development status of the main downstream application fields of China's farm animal drug industry
2.3 The current development cycle of China's farm animal drug industry
2.4 Relevant policy support for China's farm animal drug industry
2.5 The impact of the "carbon neutrality" goal on China's farm animal medicine industry
Chapter 3 Development Status of China's Farm Animal Drug Industry
3.1 Market size of China's farm animal medicine industry
3.2 Comparative analysis of the advantages and disadvantages of the development of China's farm animal medicine industry
3.3 The position of China's farm animal drug industry in the global competitive landscape
3.4 Market concentration analysis of China's farm animal drug industry
Chapter 4 Analysis of the development of farm animal drug industry in various regions of China
4.1 Analysis of the development degree of farm animal medicine industry in different regions of China
4.2 Overview of the development of farm animal medicine industry in North China
4.2.1 Development status of farm animal medicine industry in North China
4.2.2 Analysis of the advantages and disadvantages of the development of the farm animal drug industry in North China
4.3 Overview of the development of farm animal medicine industry in East China
4.3.1 Development status of farm animal medicine industry in East China
4.3.2 Analysis of the advantages and disadvantages of the development of farm animal medicine industry in East China
4.4 Overview of the development of farm animal medicine industry in South China
4.4.1 Development status of farm animal medicine industry in South China
4.4.2 Analysis of the advantages and disadvantages of the development of farm animal medicine industry in South China
4.5 Overview of the development of farm animal medicine industry in Central China
4.5.1 Development status of farm animal medicine industry in central China
4.5.2 Analysis of the advantages and disadvantages of the development of farm animal medicine industry in central China
Chapter 5 Import and export of China's farm animal medicine industry
5.1 Analysis of the import situation of China's farm animal drug industry
5.2 Analysis of the export situation of China's farm animal drug industry
5.3 Analysis of the difference between imports and exports of China's farm animal medicine industry
5.4 The impact of Sino-US trade frictions on the import and export of China's farm animal medicine industry
Chapter 6 Breakdown of Product Categories in China's Farm Animal Drug Industry
6.1 Sales volume and market share of product types in China's farm animal medicine industry
6.1.1 Sales to other locations in China
6.1.2 Oral sales in China
6.1.3 Partial sales in China
6.1.4 Gastrointestinal/gastrointestinal sales in China
6.2 Sales and market share of product categories in China's farm animal medicine industry
6.2.1 Sales in other locations in China
6.2.2 Oral sales in China
6.2.3 Partial sales in China
6.2.4 Gastrointestinal/gastrointestinal sales in China
6.3 Sales prices of product categories in China's farm animal medicine industry
6.4 Factors influencing product price fluctuations in China's farm animal medicine industry
6.4.1 Cost
6.4.2 Supply and Demand
6.4.3 Miscellaneous
Chapter 7 Application Market Analysis of China's Farm Animal Drug Industry
7.1 Downstream client analysis in the terminal application field
7.2 Sales volume and market share of farm animal drugs in China by application field
7.2.1 Sales of farm animal drugs in the field of ruminants in China
7.2.2 Sales of farm animal drugs in poultry in China
7.2.3 Sales of farm animal drugs in the livestock sector in China
7.2.4 Sales of farm animal drugs in the pig sector in China
7.2.5 Sales of farm animal drugs in the equine sector in China
7.3 Sales and market share of farm animal drugs in China by application field
7.3.1 Sales of Chinese farm animal drugs in the field of ruminants
7.3.2 Sales of farm animal drugs in poultry in China
7.3.3 Sales of farm animal drugs in the livestock sector in China
7.3.4 Sales of Chinese farm animal drugs in the pig sector
7.3.5 Sales of farm animal drugs in the equine sector in China
7.4 Application status and potential in the main fields of China's farm animal medicine industry
7.5 The impact of changes in downstream demand on the development of China's farm animal drug industry
Chapter 8 Analysis of the International Competitiveness of Enterprises in China's Farm Animal Drug Industry
8.1 Geographical distribution of major enterprises in China's farm animal medicine industry
8.2 Enterprises with international influence in China's farm animal medicine industry
8.3 Analysis of the advantages and disadvantages of Chinese farm animal medicine industry enterprises in global competition
Chapter 9 Analysis of Enterprises in China's Farm Animal Drug Industry
9.1 Alembic Animal Health
9.1.1 Alembic Animal Health基本情况
9.1.2 Introduction to Alembic Animal Health's main products and services
9.1.3 Alembic Animal Health's farm animal drug sales volume, sales revenue, price, gross profit and gross margin
9.1.4 Alembic Animal Health Corporate Development Strategy
9.2 Ashish Life Sciences
9.2.1 Ashish Life Sciences基本情况
9.2.2 Introduction to the main products and services of Ashish Life Sciences
9.2.3 Ashish Life Sciences' farm animal drug sales volume, sales revenue, price, gross profit and gross margin
9.2.4 Ashish Life Sciences' Corporate Development Strategy
9.3 Bayer AG
9.3.1 Basic facts about Bayer AG
9.3.2 Introduction to the main products and services of Bayer AG
9.3.3 Bayer AG Farm Animal Drug Sales Volume, Sales Revenue, Price, Gross Profit and Gross Margin
9.3.4 Bayer AG's corporate development strategy
9.4 Boehringer Ingelheim GmbH
9.4.1 Boehringer Ingelheim GmbH基本情况
9.4.2 Introduction to the main products and services of Boehringer Ingelheim GmbH
9.4.3 Boehringer Ingelheim GmbH Farm Animal Drug Sales Volume, Sales Revenue, Price, Gross Profit and Gross Margin
9.4.4 Boehringer Ingelheim GmbH's corporate development strategy
9.5 Ceva Sante Animal
9.5.1 Ceva Sante Animal基本情况
9.5.2 Introduction to the main products and services of Ceva Sante Animale
9.5.3 Ceva Sante Animale Farm Animal Drug Sales Volume, Sales Revenue, Price, Gross Profit and Gross Margin
9.5.4 Ceva Sante Animal企业发展战略
9.6 Dechra Pharmaceuticals PLC
9.6.1 Dechra Pharmaceuticals PLC基本情况
9.6.2 Dechra Pharmaceuticals PLC主要产品和服务介绍
9.6.3 Dechra Pharmaceuticals PLC农场动物药销售量、销售收入、价格、毛利及毛利率
9.6.4 Dechra Pharmaceuticals PLC企业发展战略
9.7 Elanco Animal Health (Sub. Eli Lilly)
9.7.1 Elanco Animal Health (Sub. Eli Lilly)基本情况
9.7.2 Elanco Animal Health (Sub. Eli Lilly)主要产品和服务介绍
9.7.3 Elanco Animal Health (Sub. Eli Lilly)农场动物药销售量、销售收入、价格、毛利及毛利率
9.7.4 Elanco Animal Health (Sub. Eli Lilly)企业发展战略
9.8 Hester Biosciences
9.8.1 Hester Biosciences基本情况
9.8.2 Introduction to Hester Biosciences' main products and services
9.8.3 Hester Biosciences Farm Animal Drug Sales Volume, Sales Revenue, Price, Gross Profit and Gross Margin
9.8.4 Hester Biosciences Corporate Development Strategy
9.9 Intas Animal Health
9.9.1 Intas Animal Health基本情况
9.9.2 Introduction to Intas Animal Health's main products and services
9.9.3 Intas Animal Health's farm animal drug sales volume, sales revenue, price, gross profit and gross margin
9.9.4 Intas Animal Health企业发展战略
9.10 Kioritsu Cheyyaku Corporation
9.10.1 Kyoritsu Seiyaku Corporation Basic Information
9.10.2 Introduction of Kyoritsu Seiyaku Corporation's Main Products and Services
9.10.3 Kyoritsu Seiyaku Corporation Farm Animal Drug Sales Volume, Sales Revenue, Price, Gross Profit and Gross Profit Margin
9.10.4 Kyoritsu Seiyaku Corporation's Corporate Development Strategy
9.11 Merck Animal Health
9.11.1 Merck Animal Health基本情况
9.11.2 Introduction to Merck Animal Health's main products and services
9.11.3 Merck Animal Health's sales volume, sales revenue, price, gross profit and gross profit margin
9.11.4 Merck Animal Health企业发展战略
9.12 Nippon Zenyaku Kogyo Co., Ltd.
9.12.1 Nippon Zenyaku Kogyo Co., Ltd Basic Information
9.12.2 Introduction of Nippon Zenyaku Kogyo Co., Ltd's Main Products and Services
9.12.3 Nippon Zenyaku Kogyo Co., Ltd Farm Animal Drug Sales Volume, Sales Revenue, Price, Gross Profit and Gross Profit Margin
9.12.4 Nippon Zenyaku Kogyo Co., Ltd's Corporate Development Strategy
9.13 Norbrook
9.13.1 Norbrook Facts
9.13.2 Introduction to Norbrook's main products and services
9.13.3 Norbrook Farms Animal Drug Sales Volume, Sales Revenue, Price, Gross Profit and Gross Profit Margin
9.13.4 Norbrook's Corporate Development Strategy
9.14 Ouro Fino Animal Health (Ourofino)
9.14.1 Ouro Fino Animal Health (Ourofino)基本情况
9.14.2 Ouro Fino Animal Health (Ourofino)主要产品和服务介绍
9.14.3 Ouro Fino Animal Health (Ourofino)农场动物药销售量、销售收入、价格、毛利及毛利率
9.14.4 Ouro Fino Animal Health (Ourofino)企业发展战略
9.15 Phibro Animal Health Corporation
9.15.1 Phibro Animal Health Corporation基本情况
9.15.2 Phibro Animal Health Corporation主要产品和服务介绍
9.15.3 Phibro Animal Health Corporation农场动物药销售量、销售收入、价格、毛利及毛利率
9.15.4 Phibro Animal Health Corporation企业发展战略
9.16 Sequent Scientific
9.16.1 Sequent Scientific基本情况
9.16.2 Sequent Scientific主要产品和服务介绍
9.16.3 Sequent Scientific农场动物药销售量、销售收入、价格、毛利及毛利率
9.16.4 Sequent Scientific企业发展战略
9.17 Vetoquinol SA
9.17.1 Vetoquinol SA基本情况
9.17.2 Introduction to the main products and services of Vetoquinol SA
9.17.3 Vetoquinol SA Farm Animal Drug Sales Volume, Sales Revenue, Price, Gross Profit and Gross Margin
9.17.4 Vetoquinol SA Corporate Development Strategy
9.18 Virbac IN
9.18.1 Basic information of Virbac SA
9.18.2 Introduction to Virbac SA's main products and services
9.18.3 Virbac SA Farm Animal Drug Sales Volume, Sales Revenue, Price, Gross Profit and Gross Margin
9.18.4 Virbac SA's Corporate Development Strategy
9.19 Zoetis, Inc.
9.19.1 Zoetis, Inc.基本情况
9.19.2 Introduction to Zoetis, Inc.'s main products and services
9.19.3 Zoetis, Inc. Farm Animal Drug Sales Volume, Sales Revenue, Price, Gross Profit and Gross Margin
9.19.4 Zoetis, Inc.'s Corporate Development Strategy
9.20 Zydus Animal Health (Sub. Cadila Healthcare Ltd)
9.20.1 Zydus Animal Health (Sub. Cadila Healthcare Ltd)基本情况
9.20.2 Zydus Animal Health (Sub. Cadila Healthcare Ltd)主要产品和服务介绍
9.20.3 Zydus Animal Health (Sub. Cadila Healthcare Ltd)农场动物药销售量、销售收入、价格、毛利及毛利率
9.20.4 Zydus Animal Health (Sub. Cadila Healthcare Ltd)企业发展战略
Chapter 10 Analysis of the Development Prospects and Trends of China's Farm Animal Drug Industry
10.1 Drivers of China's farm animal medicine industry
10.2 Constraints on the development of China's farm animal drug industry
10.3 Market development trend of China's farm animal drug industry
10.4 Development trend of the competitive landscape of China's farm animal drug industry
10.5 Key Technology Development Trends of China's Farm Animal Drug Industry
Chapter 11 China Farm Animal Drug Industry Market Forecast
11.1 Forecast of the market size of China's farm animal drug industry
11.2 Forecast of Segmented Products in China's Farm Animal Pharmaceutical Industry
11.2.1 Forecast of sales volume of sub-products in China's farm animal medicine industry
11.2.2 China Farm Animal Medicine Industry Sales Forecast by Product Segment
11.3 Forecast of the application field of farm animal medicine in China
11.3.1 Sales volume forecast of farm animal drugs in China by application field
11.3.2 China Farm Animal Drugs Sales Forecast by Application Segment
11.4 Sales Price Forecast for Product Categories in China's Farm Animal Pharmaceutical Industry
Chapter 12 Evaluation of the Growth Value of China's Farm Animal Drug Industry
12.1 Analysis of entry barriers to China's farm animal medicine industry
12.2 Periodic assessment of returns on China's farm animal drug industry
12.3 Hot spots in the development of China's farm animal drug industry
12.4 Suggestions on the development strategy of China's farm animal drug industry
The report also provides an analysis of the competitive landscape of the farm animal drug market, including the share of China's farm animal drug industry in the global market, the market share of CR3 and CR5 companies, and also studies the sales volume, sales revenue, price, gross profit, gross profit margin and market share of farm animal drugs of major enterprises in China, the distribution of China's farm animal drug industry, import and export, and industry mergers and acquisitions. The report aims to help target users such as enterprises and relevant departments in the industry accurately understand the current market situation and industry environment, grasp market dynamics, and gain insight into the industry competition pattern through visual analysis.
Questions and answers about the report:
How are the farm animal medicine industry players selected in the report?
In order to clearly reveal the competitive landscape of the farm animal medicine industry, we analyzed not only the leading companies that have a voice in the industry, but also the small and medium-sized enterprises that play a key role and have great growth potential.
What are the main sources of market data?
Divided into primary and secondary data sources. Primary sources include interviews with key opinion leaders and industry experts and executives. Secondary sources include research on the annual and financial reports of top companies, public documents, new journals, and more. We also work with a number of third-party databases.
Can I customize the farm animal drug market report according to the needs of the business/individual?
We provide customized services that can be flexibly adjusted according to the business needs of users to achieve more detailed and targeted market analysis, help customers accurately grasp market opportunities and effectively respond to market challenges.